Related Experiment Videos

Absence of the CD44 gene prevents sarcoma metastasis

Georg F Weber1, Roderick T Bronson, John Ilagan

  • 1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. GWeber@lifespan.org

Cancer Research
|April 17, 2002
PubMed

Insights

The CD44 gene is not essential for tumor growth but plays a crucial role in preventing cancer metastasis. CD44 gene knockout mice showed aborted metastasis, highlighting its importance in cancer spread.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • The CD44 gene is implicated in cancer progression and metastasis.
  • Tumorigenesis involves genetic mutations such as those in APC and p53 genes.

Purpose of the Study:

  • To investigate the role of the CD44 gene in tumorigenesis and metastasis.
  • To determine if CD44 gene products are essential for tumor incidence, growth, or spread.

Main Methods:

  • Mice with APC (min mutation) or p53 (tm1 mutation) mutations were crossed with CD44 knockout mice.
  • Tumor incidence, survival rates, and metastasis formation were analyzed in the resulting offspring.

Main Results:

  • Absence of CD44 gene products did not impact tumor incidence or mouse survival.
  • Disruption of the CD44 gene led to significantly reduced metastasis of osteosarcomas.
  • These findings align with the known role of CD44 variants in cancer dissemination.

Conclusions:

  • CD44 gene products are not critical for initial tumor formation or growth.
  • CD44 plays a significant regulatory role in the process of cancer metastasis.

Related Concept Videos